Halo Announces Closing of the Previously Announced Private Placement For CAD $425,000 and Completion of Acquisition of Nasalbinoid Natural Devices Corp.
TORONTO–(BUSINESS WIRE)–Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce, further to the press release dated April 6, 2020, it has completed the acquisition of all of the common shares of Nasalbinoid Natural Devices Corp. (“Nasalbinoid”). The Company, through its wholly-owned subsidiary, 1245316 B.C. Ltd. (“Subco”) acquired…
Details